Table 1.
Patient characteristics (n=108)
| Characteristics | Intervention group (n=56) | Control group (n=52) |
|---|---|---|
|
| ||
| Male (%) | 38 (66.7) | 34 (64.2) |
| Age in categories (years) | ||
| 50–59 | 12 (21.4) | 6 (11.5) |
| 60–69 | 18 (32.1) | 15 (28.8) |
| 70–79 | 21 (37.5) | 21 (40.4) |
| ≥80 | 5 (8.9) | 10 (19.2) |
| Education level (%)a | ||
| Low | 2 (3.6) | 5 (9.6) |
| Moderate | 26 (46.4) | 27 (51.9) |
| High | 11 (19.6) | 6 (11.5) |
| Unknown | 17 (30.4) | 14 (26.9) |
| Diabetes duration in years (median, IQR) | 6 (4–9) | 7 (4–9) |
| Number of blood glucose–lowering medications (%) | 27 (51.9) | |
| One | 36 (64.3) | 24 (46.2) |
| Two | 18 (32.1) | 1 (1.9) |
| Three | 2 (3.6) | |
| Type of blood glucose–lowering medication(s) (%) | ||
| Metformin | 53 (94.6) | 48 (92.3) |
| Gliclazide | 13 (23.2) | 18 (34.6) |
| Tolbutamide | 9 (16.1) | 9 (17.3) |
| Other | 4 (7.2) | 2 (3.8) |
| Insulin | 11 (19.6) | 14 (26.9) |
Notes:
a
Low = no education or primary education; moderate = lower secondary education, (upper) secondary education, or post-secondary non-tertiary education (including vocational education); high = tertiary education (bachelor’s degree or higher).